Please use this identifier to cite or link to this item:
|Title:||The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial||Authors:||Bose, K.||Keywords:||Cervical spondylosis
Controlled clinical trial
|Issue Date:||1999||Citation:||Bose, K. (1999). The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial. Methods and Findings in Experimental and Clinical Pharmacology 21 (3) : 209-213. ScholarBank@NUS Repository. https://doi.org/10.1358/mf.19126.96.36.1994831||Abstract:||A randomized, double-blind, clinical trial was undertaken to assess the activity of eperisone hydrochloride (50 mg t.i.d.), a commonly used muscle relaxant, as a treatment for cervical spondylosis in 157 patients. The results showed a clear benefit of eperisone treatment with regard to pain in the nuchal region, back pain, pain in arms and shoulders, stiffness and other symptoms of cervical spondylosis, while the tolerability of the treatment was optimal.||Source Title:||Methods and Findings in Experimental and Clinical Pharmacology||URI:||http://scholarbank.nus.edu.sg/handle/10635/133835||ISSN:||03790355||DOI:||10.1358/mf.19188.8.131.524831|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 17, 2019
WEB OF SCIENCETM
checked on May 8, 2019
checked on May 14, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.